Interestingly, MTLN KD imparted a significant degree of resistance against the BSO + AF treatment, as indicated by a higher surviving fraction (normalized to no-drug plating efficiency) for siMTLN compared to siCont (Figure 4C). Here, MTLN is linked to atrial fibrillation.